RxSight CFO sells 7,765 shares after RSU vest
RxSight’s CFO had RSUs vest into common stock and sold a portion of shares solely to cover related tax withholding obligations.
Rhea-AI Filing Summary
RxSight, Inc. (RXST) reported that Chief Financial Officer Mark Wilterding had Restricted Stock Units vest and related share movements in late August 2026. On August 31, 2026, 20,441 RSUs, each representing a contingent right to one share of common stock, converted into 20,441 common shares, leaving him with 122,646 shares held directly after this derivative transaction. On September 2, 2026, he sold 7,765 common shares at $6.96 per share to cover tax withholding obligations arising from the RSU vesting, which the company states did not represent a discretionary sale. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2 | 7,765 | $6.96 | $54K |
| Exercise | Restricted Stock Unit F1, F3 | 20,441 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 20,441 | -- | -- |
Footnotes (3)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- F2. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person.
- F3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award vested on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.
Key Figures
Key Terms
Restricted Stock Unit financial
contingent right financial
tax withholding obligations financial
Service Provider financial
Equity Incentive Plan financial
FAQ
What insider transactions did RxSight (RXST) disclose for its CFO?
What are the CFO’s reported RxSight (RXST) holdings after the RSU transaction?
Were the RxSight (RXST) insider transactions under a Rule 10b5-1 plan?
What is the vesting schedule for the CFO’s RxSight (RXST) RSU award?
AI-generated analysis. How Rhea-AI works. Not financial advice.